Dupont Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-96,300
Closed -$4.06M 592
2023
Q2
$4.06M Buy
+96,300
New +$3.89M 0.2% 78
2023
Q1
Sell
-17,688
Closed -$649K 1314
2022
Q4
$649K Buy
17,688
+13,562
+329% +$536K 0.03% 478
2022
Q3
$195K Sell
4,126
-18,670
-82% -$1.21M 0.01% 887
2022
Q2
$1.63M Buy
+22,796
New +$1.67M 0.08% 266
2020
Q4
Sell
-1,574
Closed -$84K 1434
2020
Q3
$84K Sell
1,574
-10,951
-87% -$652K ﹤0.01% 1201
2020
Q2
$730K Sell
12,525
-1,742
-12% -$93.6K 0.02% 626
2020
Q1
$562K Sell
14,267
-3,446
-19% -$201K 0.01% 630
2019
Q4
$1.05M Buy
17,713
+1,606
+10% +$86.3K 0.02% 552
2019
Q3
$857K Sell
16,107
-21,710
-57% -$1.11M 0.02% 581
2019
Q2
$1.93M Sell
37,817
-1,789
-5% -$83.3K 0.04% 382
2019
Q1
$2.05M Buy
39,606
+23,889
+152% +$1.16M 0.05% 360
2018
Q4
$618K Buy
15,717
+5,724
+57% +$266K 0.02% 663
2018
Q3
$515K Hold
9,993
0.01% 706
2018
Q2
$469K Hold
9,993
0.01% 720
2018
Q1
$355K Buy
+9,993
New +$391K 0.01% 734
2017
Q4
Sell
-44,467
Closed -$2.33M 1004
2017
Q3
$2.33M Sell
44,467
-44,143
-50% -$2.46M 0.05% 321
2017
Q2
$5.18M Buy
88,610
+49,860
+129% +$2.59M 0.12% 177
2017
Q1
$1.78M Buy
38,750
+9,765
+34% +$486K 0.04% 377
2016
Q4
$1.52M Sell
28,985
-30,300
-51% -$1.47M 0.03% 384
2016
Q3
$2.64M Buy
59,285
+22,715
+62% +$985K 0.06% 249
2016
Q2
$1.39M Buy
36,570
+6,270
+21% +$275K 0.03% 369
2016
Q1
$1.25M Sell
30,300
-800
-3% -$33K 0.03% 410
2015
Q4
$1.51M Buy
+31,100
New +$1.38M 0.04% 391

Other funds holding SYNH

Dupont Capital Management's SYNH Position: Q3 2023 in Review

Dupont Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 96,300 shares — an estimated $4.06M sold.

Dupont Capital Management first reported a position in SYNH in Q4 2015 and held it in 23 quarters. The position peaked at $5.18M in Q2 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Dupont Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 96,300 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.06M.
  • Dupont Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 23 quarters.
  • Dupont Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.18M in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.